Canadian federal health agency Health Canada recently ordered a labeling update for the prescription drug Cipralex, which is the brand name for escitalopram.
The new labeling will reflect clinical trial data indicating that Cipralex can cause electrical changes in the heart, which in turn can lead to potentially life-threatening heart rhythms. According to Health Canada, the risk increases as dosage increases.
The agency recommends that patients taking Cipralex consult with a healthcare ...
continue reading...